Preventing Traction Alopecia: Understanding And Natural Prevention Strategies

Hair follicle stem cells help rebuild the lower portion of the follicle at the beginning of each new growth phase. Their behavior is controlled by a specialized microenvironment known as the hair follicle stem-cell niche.

This niche does more than store stem cells. It coordinates signals from epithelial cells, the dermal papilla, surrounding connective tissue, nerves, blood vessels, immune cells and the extracellular matrix. Together, these signals help determine whether a follicle remains at rest or enters a new growth phase.

Research into this system has improved our understanding of hair cycling, androgenetic alopecia, scarring alopecia and age-related follicular change. However, laboratory knowledge about stem-cell signaling has not yet produced a clinically proven method for permanently reactivating every inactive or miniaturized human follicle.

This review explains where hair follicle stem cells are found, how their niche regulates regeneration, what changes in common hair-loss disorders and why commercial “stem-cell” treatments should not be confused with normal stem-cell biology.

Clinical note: A visual scalp examination cannot directly confirm whether follicular stem cells remain viable. Clinical history and trichoscopy may identify miniaturization, inflammation or loss of follicular openings. A dermatologist may recommend scalp biopsy when scarring alopecia or another inflammatory disorder is suspected.

What Is the Hair Follicle Stem-Cell Niche?

A stem-cell niche is the local biological environment that maintains stem cells and regulates their behavior.

Within a hair follicle, this environment includes:

• Epithelial stem and progenitor cells.
• The bulge and secondary hair germ.
• The dermal papilla and dermal sheath.
• Extracellular matrix components.
• Immune cells.
• Peripheral nerves and arrector pili muscle connections.
• Nearby blood vessels and adipose tissue.
• Local hormones, growth factors and signaling molecules.

These elements communicate across the hair cycle. Their signals help keep stem cells relatively quiet when regeneration is not needed and help activate the regenerative program as a new anagen phase begins.^1,3,13

The niche should therefore be understood as a dynamic biological system, not simply a physical compartment containing dormant cells.

Where Are Hair Follicle Stem Cells Located?

The bulge is one of the best-studied epithelial stem-cell regions in the hair follicle. It lies in the permanent upper portion of the follicle, close to the attachment of the arrector pili muscle and below the sebaceous gland.

Classic label-retaining experiments helped identify slow-cycling cells in this area. These cells can contribute to follicular renewal and participate in epidermal repair after injury.²

However, hair regeneration does not depend on the bulge alone.

The secondary hair germ sits below the bulge during telogen, close to the dermal papilla. It contains progenitor cells that can respond early to activating signals as the follicle prepares to enter anagen.

During a new growth phase, coordinated activity within the secondary hair germ and bulge helps regenerate the cycling lower follicle. Rapidly dividing matrix cells then produce the new hair shaft and inner root sheath.

This distinction matters because “hair follicle stem cells” describes a cellular hierarchy and interacting compartments rather than one isolated group of cells performing every regenerative task.

Editorial image note: Figure 1 is preserved from the original article. Before publication, its reuse permission should be confirmed. An original Trichology.com diagram distinguishing epithelial hair follicle stem cells from melanocyte stem cells would be more accurate.

How the Hair Cycle Relates to Stem-Cell Activity

Scalp follicles repeatedly move through a cycle consisting of:

• Anagen: active growth and production of the hair shaft.
• Catagen: controlled regression of the lower follicle.
• Telogen: a relatively quiet resting phase.
• Exogen: release of the club hair from the follicle.

During catagen, much of the lower follicle regresses through controlled cell death. The permanent upper portion, including important stem-cell compartments, normally remains.

During telogen, the dermal papilla sits near the secondary hair germ. Changes in inhibitory and activating signals help determine when the follicle begins another anagen phase.

Once activation occurs, progenitor cells proliferate and help rebuild the lower follicle. The newly established matrix then produces a growing hair shaft.

This regenerative process is remarkable, but it is not unlimited. Aging, inflammation, genetic susceptibility and changes within the surrounding niche can alter how effectively follicles cycle over time.¹⁴

What Activates Hair Follicle Stem Cells?

No single molecule independently switches hair growth on or off. Instead, activation reflects the balance, timing and location of multiple signals.

Wnt/β-catenin signaling

Wnt/β-catenin signaling has a central role in hair follicle development and cycling. Appropriate Wnt activity contributes to the transition toward anagen and supports the activity of follicular progenitor cells.^5,13

Experimental suppression of this pathway can interfere with follicular development or regeneration. However, it would be misleading to describe Wnt as a simple commercial “hair-growth switch.” Its effects are context-dependent, and uncontrolled Wnt activity is not necessarily safe.

Bone morphogenetic protein signaling

Bone morphogenetic protein, or BMP, signaling helps maintain quiescence within parts of the stem-cell compartment.

A reduction in inhibitory BMP signaling can contribute to activation. However, BMP does more than keep follicles dormant. Its role changes across cell populations and stages of follicular differentiation.^6,13

TGF-β signaling

Transforming growth factor-beta signaling has several context-dependent functions within the follicle.

Research indicates that TGF-β2 from the dermal papilla can help counter BMP-mediated repression during stem-cell activation. Other TGF-β signals also participate in catagen and tissue remodeling.⁷

Hedgehog and fibroblast growth factors

Sonic Hedgehog signaling contributes to the growth and organization of the regenerating lower follicle. Fibroblast growth factors can support communication between epithelial and mesenchymal compartments, although individual FGF family members may have different or opposing functions.

Signals beyond the follicle

The niche also responds to signals from nerves, immune cells, adipose tissue, blood vessels and the systemic environment. Research has linked stress, aging, immune activity and metabolic state with changes in follicular stem-cell behavior.^3,13,14

Editorial image note: Figure 2 is preserved from the source HTML. Its licensing and scientific labeling should be reviewed. A newly commissioned diagram based on primary literature would provide clearer provenance.

Quiescence Is Not the Same as Damage

Quiescence is a normal, regulated state in which stem cells are relatively inactive but retain regenerative potential.

This is different from:

• Temporary interruption of the hair cycle.
• Progressive follicular miniaturization.
• Cellular aging or senescence.
• Failure to generate appropriate progenitor cells.
• Inflammatory injury to the stem-cell compartment.
• Permanent replacement of the follicle with scar tissue.

The phrase “dormant follicle” is often used in consumer hair-loss marketing, but it has no single precise clinical definition.

A follicle in telogen is not necessarily diseased. Likewise, a miniaturized follicle in androgenetic alopecia is not simply sleeping and waiting to be switched back on.

The biological cause, extent of structural change and duration of disease all affect whether meaningful recovery is possible.

Can a Scalp Examination Show Whether Stem Cells Are Alive?

No routine visual examination directly measures hair follicle stem cells.

A trained practitioner can assess clinically useful signs, including:

• The pattern and distribution of hair loss.
• Variation in hair-shaft diameter.
• Follicular miniaturization.
• Broken hairs or black dots.
• Redness, scaling or perifollicular inflammation.
• Preservation or loss of follicular openings.
• Signs suggesting scarring.

Trichoscopy can improve this assessment by magnifying scalp and follicular features. However, it still does not directly count stem cells or prove that a stem-cell niche is functional.

When scarring alopecia is suspected, a dermatologist may perform one or more scalp biopsies. Histopathology can evaluate inflammation, fibrosis, follicular structures and the anatomical region containing the epithelial stem-cell niche.

Hair Follicle Stem Cells in Androgenetic Alopecia

Androgenetic alopecia causes progressive follicular miniaturization in genetically susceptible scalp areas.

Androgen signaling within the dermal papilla contributes to shorter anagen phases and changes in the signals exchanged with follicular epithelial cells. Over repeated cycles, affected follicles produce shorter, finer and less pigmented hairs.

A landmark 2011 study compared balding and non-balding scalp from men with androgenetic alopecia. It found that cells expressing a keratin-associated stem-cell marker remained in balding scalp. However, populations expressing certain progenitor-cell markers were reduced.⁹

The authors concluded that impaired conversion of stem cells into progenitor cells may contribute to androgenetic alopecia.

This was an important finding, but it should not be overstated:

• It does not prove that every follicle remains indefinitely recoverable.
• It does not mean advanced androgenetic alopecia can be completely reversed.
• It does not establish one treatment that restores normal progenitor formation.
• Stem-cell markers do not by themselves prove full functional capacity.
• Aging, miniaturization and niche changes may still limit recovery.

Established treatments for androgenetic alopecia aim to slow miniaturization or support growth. They should not be described as clinically proven stem-cell reactivation therapies.

Hair Follicle Stem Cells in Telogen Effluvium

Telogen effluvium occurs when an increased number of follicles leave anagen and enter telogen following a physiological or medical trigger.

Possible triggers include:

• Major illness or fever.
• Surgery.
• Childbirth.
• Rapid weight loss.
• Restrictive dieting.
• Iron deficiency or another relevant nutritional problem.
• Thyroid disturbance.
• Certain medications.
• Severe physiological or emotional stress.

In most cases, telogen effluvium does not destroy the follicular stem-cell niche. Hair growth can resume after the trigger resolves and the follicles cycle back into anagen.

However, it is more accurate to describe telogen effluvium as altered hair-cycle timing than as a proven failure of stem-cell activation.

Persistent shedding should be assessed because chronic telogen effluvium, androgenetic alopecia and other causes of diffuse loss can overlap.

Hair Follicle Stem Cells in Alopecia Areata

Alopecia areata is an autoimmune disorder that primarily disrupts actively growing follicles.

Unlike primary scarring alopecia, the epithelial stem-cell compartment is generally preserved. This helps explain why substantial regrowth can remain possible, even after extensive loss.

However, regrowth depends on controlling the autoimmune disease. The presence of stem cells does not make alopecia areata harmless or guarantee spontaneous recovery.

Current treatment decisions depend on age, disease duration, severity, affected sites and medical circumstances. They may include corticosteroids, contact immunotherapy, JAK inhibitors or other dermatologist-directed treatment.

Hair Follicle Stem Cells in Scarring Alopecia

Primary cicatricial or scarring alopecias involve inflammatory damage to the follicle. Examples include:

• Lichen planopilaris.
• Frontal fibrosing alopecia.
• Central centrifugal cicatricial alopecia.
• Discoid lupus erythematosus affecting the scalp.
• Folliculitis decalvans.

When inflammation irreversibly damages the epithelial stem-cell region and the follicle is replaced by fibrous tissue, that follicle can no longer produce hair.^10,15

Early treatment is therefore crucial. The medical priority is normally to suppress active inflammation and preserve follicles that remain.

Hair-growth stimulants alone cannot regenerate a follicle that has been completely destroyed and replaced by scar tissue.

Aging and the Stem-Cell Niche

Hair follicles change with age through multiple interacting mechanisms.

Research suggests that aging can affect:

• Stem-cell identity and maintenance.
• Cell adhesion within the niche.
• DNA-damage responses.
• Extracellular matrix composition.
• Communication with melanocyte stem cells.
• Immune and inflammatory signaling.
• Regenerative efficiency across repeated cycles.

Animal research has shown that aging hair follicle stem cells may leave the bulge and be lost from the niche. Other studies have investigated changes in stem-cell fate, adhesion and tissue architecture.^14,16

These findings offer important biological insight. However, mechanisms demonstrated in mice should not automatically be presented as confirmed therapeutic targets in humans.

Do Hormones, Nutrition and Stress Affect the Niche?

Hair follicles respond to the wider physiological environment, but the relationship requires careful wording.

Hormones

Androgen signaling is central to androgenetic alopecia. Thyroid dysfunction, major reproductive changes and other hormonal conditions can also alter hair cycling.

It is still too broad to say that an undefined “hormonal imbalance” prevents stem cells from working. The relevant hormone, diagnosis and pathway must be identified.

Nutrition

Protein-energy deficiency and deficiencies involving iron, zinc or other nutrients can contribute to shedding when clinically present.

Correcting a confirmed deficiency can support normalization of the hair cycle. It should not be marketed as directly activating follicular stem cells, and taking extra supplements without a deficiency does not guarantee better regeneration.

Stress

Experimental research has identified pathways through which stress signaling can influence follicular cycling and stem-cell behavior. Human stress-related shedding is usually discussed clinically within the context of telogen effluvium.

Stress should not be blamed for every unexplained hair-loss condition, particularly when signs of autoimmune, inflammatory, genetic or scarring disease are present.

Does Current Hair-Loss Treatment Reactivate Stem Cells?

Established treatments can improve growth or slow loss through several mechanisms. However, describing them as proven stem-cell reactivation treatments is usually too simplistic.

What About Stem-Cell and Exosome Treatments for Hair Loss?

Normal hair follicle stem cells should not be confused with commercial treatments advertised using terms such as:

• Stem-cell injections.
• Stem-cell conditioned media.
• Adipose-derived regenerative cells.
• Exosome therapy.
• Follicular cell suspensions.
• Regenerative growth-factor treatment.

Early studies have investigated several cell-based and cell-derived approaches for androgenetic alopecia. Some report encouraging changes in hair density, but the research remains limited by small samples, inconsistent preparation methods, different outcome measures and limited long-term evidence.^17,18

These interventions are not interchangeable. A treatment containing cells is different from conditioned media, platelet-rich plasma or an exosome product.

The U.S. Food and Drug Administration has warned that many products marketed as regenerative medicine, including some stem-cell and exosome products, are unapproved. Consumers should not assume that “natural,” “autologous” or “regenerative” means proven or risk-free.¹⁹

Clinical Implications for Trichology Practice

Stem-cell biology helps explain why clinical diagnosis and early intervention matter.

In practice, the most useful questions are not simply whether a follicle is “alive” or “dead.” A more complete assessment asks:

• What pattern of hair loss is present?
• Are follicles miniaturizing?
• Is shedding increased?
• Are visible follicular openings preserved?
• Is there scalp inflammation?
• Are there signs suggesting scarring?
• Is medical referral needed?
• Is a biopsy or laboratory investigation appropriate?
• Which established treatments match the diagnosis?

A trichologist can contribute through history-taking, scalp and hair examination, trichoscopy where appropriately trained, monitoring and referral.

However, trichologists are not automatically medical doctors. Diagnosis of complex inflammatory disease, prescription treatment and scalp biopsy belong with an appropriately qualified medical clinician, usually a dermatologist.

Frequently Asked Questions

What are hair follicle stem cells?

Hair follicle stem cells are regenerative epithelial cells found in specialized follicular compartments, especially the bulge. Together with progenitor cells in regions such as the secondary hair germ, they help rebuild the cycling portion of the follicle.

What is the hair follicle stem-cell niche?

It is the local environment that maintains and regulates follicular stem cells. It includes neighboring cells, extracellular matrix, the dermal papilla, immune and nerve signals, blood vessels and molecular signaling pathways.

Are hair follicle stem cells responsible for hair growth?

They are essential to follicular regeneration, but they do not work alone. Hair growth requires coordinated interaction between stem cells, progenitor cells, the dermal papilla, matrix cells and the surrounding tissue.

Can hair follicles be dormant but still alive?

Follicles normally enter a resting telogen phase. Miniaturized or temporarily inactive follicles may also remain structurally present. However, “dormant follicle” is not a precise diagnosis, and visual examination cannot directly confirm stem-cell viability.

Can a trichologist tell whether my stem cells are alive?

Not directly. A trichologist may identify clinical signs suggesting non-scarring or scarring loss and recommend referral. Direct evaluation of follicular tissue may require examination and biopsy by a dermatologist.

Do hair follicle stem cells disappear in androgenetic alopecia?

A human study found retained stem-cell markers but reduced progenitor-cell populations in balding scalp. This suggests impaired stem-to-progenitor conversion may contribute, but it does not prove that every miniaturized follicle can be fully restored.

Why is scarring alopecia permanent?

Inflammation can irreversibly damage the follicle, including its epithelial stem-cell region. Once the follicle is replaced by scar tissue, it cannot regenerate a new hair shaft.

Can damaged hair follicles regenerate?

That depends on the type and extent of damage. Follicles affected by temporary cycling disruption may recover. Miniaturized follicles may respond partially to treatment. Completely destroyed and scarred follicles cannot regenerate naturally.

Do supplements activate hair follicle stem cells?

No supplement has been established as a universal stem-cell activator. Correcting a confirmed nutritional deficiency may support normalization of hair cycling, but extra supplementation does not guarantee regrowth and can sometimes cause harm.

Are stem-cell injections proven to regrow hair?

Cell-based and cell-derived treatments remain investigational. Small studies have reported promising findings, but preparations and protocols vary, and long-term efficacy and safety are not established.

Are exosomes the same as stem cells?

No. Exosomes are small extracellular vesicles released by cells. They are not living stem cells. Commercial exosome treatments should not be assumed safe, approved or effective simply because they are described as regenerative.

Can scientists create completely new human hair follicles?

Researchers are investigating follicular tissue engineering, organoids and cell-based follicle generation. Creating cosmetically useful, correctly oriented and consistently cycling human follicles remains an experimental challenge rather than a routine clinical treatment.

Conclusion

The hair follicle stem-cell niche is a dynamic biological system that enables follicles to regenerate across repeated hair cycles.

Epithelial stem cells in the bulge, progenitor cells in the secondary hair germ and signals from the dermal papilla and surrounding tissue all contribute to this process. Wnt, BMP, TGF-β, Hedgehog and FGF pathways help coordinate the balance between quiescence, activation and differentiation.

Research also helps explain why hair-loss disorders behave differently. Androgenetic alopecia involves progressive miniaturization and altered progenitor activity. Telogen effluvium usually changes hair-cycle timing without destroying the follicle. Alopecia areata generally preserves the stem-cell compartment, while scarring alopecia can irreversibly destroy it.

What this really means is that stem-cell biology can improve our understanding of disease, but it should not be turned into a promise that every thinning follicle can be “reactivated.” Clinical decisions must still be based on diagnosis, established evidence and realistic expectations.

References

1. Cotsarelis G. Epithelial stem cells: a folliculocentric view. Journal of Investigative Dermatology. 2006;126(7):1459–1468. doi:10.1038/sj.jid.5700376
2. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61(7):1329–1337. doi:10.1016/0092-8674(90)90696-C
3. Hsu YC, Li L, Fuchs E. Emerging interactions between skin stem cells and their niches. Nature Medicine. 2014;20(8):847–856. doi:10.1038/nm.3643
4. Paus R, Cotsarelis G. The biology of hair follicles. New England Journal of Medicine. 1999;341(7):491–497. doi:10.1056/NEJM199908123410706
5. Andl T, Reddy ST, Gaddapara T, Millar SE. WNT signals are required for the initiation of hair follicle development. Developmental Cell. 2002;2(5):643–653. doi:10.1016/S1534-5807(02)00167-3
6. Genander M, Cook PJ, Ramsköld D, et al. BMP signaling and its pSMAD1/5 target genes differentially regulate hair follicle stem cell lineages. Cell Stem Cell. 2014;15(5):619–633. doi:10.1016/j.stem.2014.09.009
7. Oshimori N, Oristian D, Fuchs E. TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell. 2012;10(1):63–75. doi:10.1016/j.stem.2011.11.005
8. Nowak JA, Polak L, Pasolli HA, Fuchs E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell. 2008;3(1):33–43. doi:10.1016/j.stem.2008.05.009
9. Garza LA, Yang CC, Zhao T, et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive progenitor cells. Journal of Clinical Investigation. 2011;121(2):613–622. doi:10.1172/JCI44478
10. Harries MJ, Paus R. The pathogenesis of primary cicatricial alopecias. American Journal of Pathology. 2010;177(5):2152–2162. doi:10.2353/ajpath.2010.100454
11. Huang L, Zuo Y, Li S, Li C. Melanocyte stem cells in the skin: origin, biological characteristics, homeostatic maintenance and therapeutic potential. Clinical and Translational Medicine. 2024. Source page for the preserved figure.
12. Scientific Archives. Hair Follicle Stem Cells: The Signaling Hub of the Skin. Source page for the preserved figure.
13. Lee JH, et al. Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration and diseases. Experimental & Molecular Medicine. 2024. PubMed Central full text.
14. Jang H, et al. Aging of hair follicle stem cells and their niches. BMB Reports. 2023;56(1):2–9. PubMed Central full text.
15. Halley-Stott RP, et al. Destruction of the stem cell niche, pathogenesis and treatment of primary scarring alopecias. Clinical and Experimental Dermatology. 2020. PubMed record.
16. Zhang C, et al. Escape of hair follicle stem cells causes stem cell exhaustion during aging. Nature Aging. 2021. NIH Research Matters summary.
17. Krefft-Trzciniecka K, et al. Human stem cell use in androgenetic alopecia: a systematic review. 2023. PubMed Central full text.
18. Gasteratos K, et al. Autologous stem cell-derived therapies for androgenetic alopecia: a systematic review and meta-analysis. 2024. PubMed Central full text.
19. U.S. Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies. FDA consumer information.

Medical and scientific disclaimer: This Journal article is for professional education and general information. It does not replace medical diagnosis, histopathology or treatment. Findings from cell culture and animal models do not always translate into effective human treatment. Stem-cell, conditioned-media and exosome procedures for hair loss remain investigational and may be subject to different regulatory requirements. Seek assessment from an appropriately qualified medical clinician for painful, inflamed, rapidly progressive or potentially scarring hair loss.